SAREPTA THERAPEUTICS, INC. Available-for-sale Securities, Gross Unrealized Gain
SAREPTA THERAPEUTICS, INC. (SRPT) reported Available-for-sale Securities, Gross Unrealized Gain of $0 for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2015-08-06
- SAREPTA THERAPEUTICS, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2015-06-30 was $0.00.
- SAREPTA THERAPEUTICS, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2015-03-31 was $0.00.
- SAREPTA THERAPEUTICS, INC. available-for-sale securities, gross unrealized gain for the quarter ending 2014-12-31 was -$1.00K.
- SAREPTA THERAPEUTICS, INC. available-for-sale securities, gross unrealized gain for fiscal 2013 was $0.00.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|---|---|---|
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | -$1.00K derived: sum of 3 quarters · filed 2015-08-06 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | -$1.00K derived: sum of 2 quarters · filed 2015-08-06 | ||
| 2014-12-31 | -$1.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | ||
| 2014-09-30 | $1.00K 10-Q · filed 2014-11-06 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |